acoramidis 356 MG (as acoramidis hydrochloride 400 MG) Oral Tablet
- RxCUI
- 2698318
- RxNorm name
- acoramidis 356 MG (as acoramidis hydrochloride 400 MG) Oral Tablet
- Display name
- acoramidis 356 MG (as acoramidis hydrochloride 400 MG) Oral Tablet
- Full name
- acoramidis 356 MG (as acoramidis hydrochloride 400 MG) Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Attruby | ACORAMIDIS HYDROCHLORIDE | BridgeBio Pharma, Inc. | 913552ef-875d-4cb7-bf05-a7d20a394c38 | 2026-06-29 | Adverse reactions | 2698318 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 913552ef-875d-4cb7-bf05-a7d20a394c38 | acoramidis 356 MG Oral Tablet [PSN] · acoramidis 356 MG Oral Tablet [SCD] · acoramidis 356 MG (as acoramidis hydrochloride 400 MG) Oral Tablet [SY] | 3 | 6 | These highlights do not include all the information needed to use ATTRUBY safely and effectively. See full prescribing information for ATTRUBY. ATTRUBY ™ (acoramidis) tablets, for oral administration, Initial U.S. Approval: 2024 | 20251216 |